FDA approves Pfizer RSV vaccine for older adults

FDA approves Pfizer RSV vaccine for older adults The Food and Drug Administration (FDA) on Wednesday approved Pfizer’s vaccine to prevent the respiratory disease RSV in older adults, the company announced. After decades without any RSV shot… nweixel The Hill

...

The approval of Pfizer’s Abrysvo marks the second authorized RSV shot for older adults in the U.S. this month, after GlaxoSmithKline (GSK) won approval for its rival shot, Arexvy.

The agency is also considering Pfizer’s maternal RSV vaccine, intended to be given to pregnant individuals to help protect against RSV in infants. A monoclonal antibody treatment from Sanofi and AstraZeneca is also under review.

...